Page 78 - GPD-2-2

Gene & Protein in Disease Genetics of arteriovenous malformations

management strategies, novel therapeutic approaches, arteriovenous malformations from the modern decade.
and more personalized care. Neurosurgery, 77(6): 948–953.
https://doi.org/10.1227/NEU.0000000000000968
Acknowledgments
5. Xiaochuan H, Yuhua J, Xianli L, et al., 2015, Targeted
None. embolization reduces hemorrhage complications in partially
embolized cerebral AVM combined with gamma knife
Funding surgery. Interv Neuroradiol, 21(1): 80–87.
No funding or financial support was received for this work. https://doi.org/10.15274/INR-2014-10090
Conflict of interest 6. Kim H, Marchuk DA, Pawlikowska L, et al., 2008, Genetic
considerations relevant to intracranial hemorrhage and
The authors have no personal, financial, or institutional brain arteriovenous malformations. Acta Neurochir Suppl,
interest in any of the drugs, materials, or devices described 105: 199-206.
in this article.
https://doi.org/10.1007/978-3-211-09469-3_38
Author contributions 7. Rangel-Castilla L, Russin JJ, Martinez-del-Campo E,
et al., 2014, Molecular and cellular biology of cerebral
Conceptualization: Krisna Maddy, Brandon Lucke-Wold arteriovenous malformations: A review of current concepts
Writing – original draft: Krisna Maddy, Anjalika and future trends in treatment. Neurosurg Focus, 37(3): E1.
Chalamgari, Ogechukwu Ariwodo, Zhuri Nisseau- https://doi.org/10.3171/2014.7.FOCUS14214
Bey, Justin Maldonado
Writing – review & editing: Krisna Maddy, Anjalika 8. Shenkar R, Elliott JP, Diener K, et al., 2003, Differential
Chalamgari, Ogechukwu Ariwodo, Brandon Lucke- gene expression in human cerebrovascular malformations.
Wold Neurosurgery, 52(2): 465–478.
https://doi.org/10.1227/01.NEU.0000044131.03495.22
Ethics approval and consent to participate
9. Shaligram SS, Winkler E, Cooke D, et al., 2019, Risk factors
Not applicable. for hemorrhage of brain arteriovenous malformation. CNS
Neurosci Ther, 25(10): 1085–1095.
Consent for publication
https://doi.org/10.1111/cns.13200
Not applicable.
10. Begbie ME, Wallace GM, Shovlin CL, 2003, Hereditary
Availability of data haemorrhagic telangiectasia (Osler-Weber-Rendu
syndrome): A view from the 21 century. Postgrad Med J,
st
Not applicable. 79(927): 18–24.
References https://doi.org/10.1136/pmj.79.927.18
11. Solomon RA, Connolly ES Jr., 2017, Arteriovenous
1. Chen CJ, Ding D, Derdeyn C, et al., 2020, Brain arteriovenous malformations of the brain. N Engl J Med, 376(19): 1859–
malformations: A review of natural history, pathobiology,
and interventions. Neurology, 95(20): 917–927. 1866.
https://doi.org/10.1056/NEJMra1607407
https://doi.org/10.1212/WNL.0000000000010968
12. Osbun JW, Reynolds MR, Barrow DL, 2017, Arteriovenous
2. Schimmel K, Ali MK, Tan SY, et al., 2021, Arteriovenous malformations. Handb Clin Neurol, 143: 25–29.
malformations-current understanding of the pathogenesis
with implications for treatment. Int J Mol Sci, 22(16): 9037. https://doi.org/10.1016/B978-0-444-63640-9.00003-5
https://doi.org/10.3390/ijms22169037 13. Ferrara AR, 2011, Brain arteriovenous malformations.
Radiol Technol, 82(6): 543MR–56MR.
3. Daou BJ, Palmateer G, Thompson BG, et al., 2020, Stereotactic
radiosurgery for brain arteriovenous malformations: 14. Delev D, Pavlova A, Grote A, et al., 2017, NOTCH4
Evaluation of obliteration and review of associated predictors. gene polymorphisms as potential risk factors for brain
J Stroke Cerebrovasc Dis, 29(8): 104863. arteriovenous malformation development and hemorrhagic
presentation. J Neurosurg, 126(5): 1552–1559.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104863
https://doi.org/10.3171/2016.3.JNS151731
4. Moon K, Levitt MR, Almefty RO, et al., 2015, Safety and
efficacy of surgical resection of unruptured low-grade 15. Krithika S, Sumi S, 2021, Neurovascular inflammation in the

Volume 2 Issue 2 (2023) 12 https://doi.org/10.36922/gpd.0312